Connect with us

Hi, what are you looking for?

News

Collegium: Turning More Constructive, Especially At 4.4x Earnings (NASDAQ:COLL)

Investment Summary

Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) underperformed the last quarter in-line with my neutral rating on the company back in January. Rolling forward 1 period, I am turning more constructive on the company. I

4

Data: Updata

4

Data: Author, COLL SEC Filings

4

Data: Author Estimates

4

Data: Author, COLL SEC Filings

r

Data: Author, COLL SEC Filings

r

Data: Author, COLL SEC Filings

r

Data: Author, COLL SEC Filings

4

Data: Author Estimates

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube